Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 12-Week, Placebo-Controlled Phase 3 Trial (T3MPO-1)

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2)

Am J Gastroenterol

Chey WD, Lembo AJ, Yang Y, Rosenbaum DP

doi: 10.14309/ajg.0000000000001056

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Curr Med Res Opin.

Barish CF, Crozier RA, Griffin P

doi: 10.1080/03007995.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Efficacy and Safety of 5-HT4 Receptor Agonist Minesapride for Irritable Bowel Syndrome with Constipation in a Randomized Controlled Trial

Clin Gastroenterol Hepatol.

Fukudo S, Nakamura M, Hamatani T, Kazumori K, Miwa H

doi: 10.1016/j.cgh.2020.03.019.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome

Aliment Pharmacol Ther.

Saito YA, Almazar AE, Tilkes KE, Choung RS, Van Norstrand MD, Schleck CD, Zinsmeister AR, Talley NJ

doi: 10.1111/apt.15077.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study

Am J Gastroenterol.

Brenner DM, Sayuk GS, Gutman CR, Jo E, Elmes SJR, Liu LWC, Cash BD

doi: 10.14309/ajg.0000000000000327.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation

Clin Gastroenterol Hepatol.

Ballou S, Beath A, Kaptchuk TJ, Hirsch W, Sommers T, Nee J, Iturrino J, Rangan V, Singh P, Jones M, Lembo A

doi: 10.1016/j.cgh.2018.04.009.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

Lancet Gastroenterol Hepatol.

Aroniadis OC, Brandt LJ, Oneto C, Feuerstadt P, Sherman A, Wolkoff AW, Kassam Z, Sadovsky RG, Elliott RJ, Budree S, Kim M, Keller MJ

doi: 10.1016/S2468-1253

RECOMMENDED

Irritable Bowel Syndrome (IBS) and Chronic Constipation

Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial

★ 2 Recommended by Prof. Dr Stephan Vavricka, Faculty Member

doi: 10.1016/S2468-1253(20)30056-X.

ColonoscopyGastrointestinal CancerInflammatory Bowel Disease

Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet Gastroenterol Hepatol.

Taha AS, McCloskey C, McSkimming P, McConnachie A

doi: 10.1016/

Related content

Efficacy of Tenapanor in Treating Patients With Irritable Bowel Syndrome With Constipation: A 26-Week, Placebo-Controlled Phase 3 Trial (T3MPO-2)

Irritable Bowel Syndrome (IBS) and Chronic Constipation Long-term treatment with plecanatide was safe and tolerable in patients with irritable bowel syndrome with constipation

Efficacy and Safety of 5-HT4 Receptor Agonist Minesapride for Irritable Bowel Syndrome with Constipation in a Randomized Controlled Trial

Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome

Efficacy and Safety of Eluxadoline in Patients With Irritable Bowel Syndrome With Diarrhea Who Report Inadequate Symptom Control With Loperamide: RELIEF Phase 4 Study

Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial

Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial